OTC · CIK 0001566826
LGMK LogicMark, Inc.
Insider trading from SEC Form 4. Last filing Mar 31, 2025. Close $1.00 on Oct 9, 2026, +133% from the 52-week low and -67% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Price and insider trades, last year
LGMKOct 9, 2026 · close 1.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at LogicMark, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Winvest Investment Fund Management Corp. owner buy | $114k 1,257,257 shares | +45% | - | |
| 31Weak | Winvest Investment Fund Management Corp. owner buy | $307k 3,464,987 shares | +568% | - |
Transactions
The last 28 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Robert Arthur Curtis director | AGrant or award Series A Common Stock Purchase Warrantderivative | +67,794 | $0.13 | $8,474 | 84,742 | Mar 31, 2025 |
| Mar 27, 2025 | Barbara Gutierrez director | AGrant or award Series A Common Stock Purchase Warrantderivative | +67,794 | $0.13 | $8,474 | 84,742 | Mar 31, 2025 |
| Mar 27, 2025 | Mark Archer Chief Financial Officer | AGrant or award Series A Common Stock Purchase Warrantderivative | +67,794 | $0.13 | $8,474 | 84,742 | Mar 31, 2025 |
| Feb 18, 2025 | Mark Archer Chief Financial Officer | AGrant or award Series A Common Stock Purchase Warrantderivative | +11,238 | $0.13 | $1,405 | 16,948 | Feb 20, 2025 |
| Feb 18, 2025 | Robert Arthur Curtis director | AGrant or award Series A Common Stock Purchase Warrantderivative | +11,238 | $0.13 | $1,405 | 16,948 | Feb 20, 2025 |
| Feb 18, 2025 | Barbara Gutierrez director | AGrant or award Series A Common Stock Purchase Warrantderivative | +11,238 | $0.13 | $1,405 | 16,948 | Feb 20, 2025 |
| Jan 2, 2025 | Mark Archer Chief Financial Officer | AGrant or award Common Stock | +38,000 | $0.00 | $0 | 39,955 | Jan 6, 2025 |
| Jan 2, 2025 | Robert Arthur Curtis director | AGrant or award Options to Purchasederivative | +6,667 | $0.00 | $0 | 6,667 | Jan 6, 2025 |
| Jan 2, 2025 | Barbara Gutierrez director | AGrant or award Options to Purchasederivative | +6,667 | $0.00 | $0 | 6,667 | Jan 6, 2025 |
| Jan 2, 2025 | Mark Archer Chief Financial Officer | AGrant or award Common Stockindirect: By FLG Partners, LLC | +2,000 | $0.00 | $0 | 2,058 | Jan 6, 2025 |
| Nov 26, 2024 | Barbara Gutierrez director | AGrant or award Series A Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | John P Pettitt director | AGrant or award Series A Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Chia-Lin Simmons President and CEO | AGrant or award Series A Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Carine Schneider director | AGrant or award Series A Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Robert Arthur Curtis director | AGrant or award Series A Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Mark Archer Chief Financial Officer | AGrant or award Series A Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Robert Arthur Curtis director | AGrant or award Series B Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Barbara Gutierrez director | AGrant or award Series B Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Carine Schneider director | AGrant or award Series B Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Mark Archer Chief Financial Officer | AGrant or award Series B Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | Chia-Lin Simmons President and CEO | AGrant or award Series B Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Nov 26, 2024 | John P Pettitt director | AGrant or award Series B Common Stock Purchase Warrantderivative | +4,851 | $0.13 | $606 | 5,710 | Nov 29, 2024 |
| Oct 15, 2024 | Winvest Investment Fund Management Corp. owner | POpen-market purchase Common Stock, par value $0.0001 per share | +232,857 | $0.09 | $21k | 3,050,187 | Nov 12, 2024 |
| Oct 16, 2024 | Winvest Investment Fund Management Corp. owner | POpen-market purchase Common Stock, par value $0.0001 per share | +1,024,400 | $0.09 | $93k | 4,074,587 | Nov 12, 2024 |
| Oct 9, 2024 | Winvest Investment Fund Management Corp. owner | POpen-market purchase Common Stock, par value $0.0001 per share | +336,100 | $0.10 | $35k | 945,700 | Oct 18, 2024 |
| Oct 10, 2024 | Winvest Investment Fund Management Corp. owner | POpen-market purchase Common Stock, par value $0.0001 per share | +380 | $0.09 | $36 | 946,080 | Oct 18, 2024 |
| Oct 15, 2024 | Winvest Investment Fund Management Corp. owner | POpen-market purchase Common Stock, par value $0.0001 per share | +2,104,107 | $0.08 | $179k | 3,050,187 | Oct 18, 2024 |
| Oct 16, 2024 | Winvest Investment Fund Management Corp. owner | POpen-market purchase Common Stock, par value $0.0001 per share | +1,024,400 | $0.09 | $93k | 4,074,587 | Oct 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Mark ArcherChief Financial Officer
- Robert Arthur Curtisdirector
- Barbara Gutierrezdirector
- John P Pettittdirector
- Carine Schneiderdirector
- Chia-Lin SimmonsPresident and CEO
- Winvest Investment Fund Management Corp.owner
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.